Varian Medical Systems, Inc., Elekta AB and Accuray are Dominating the Market for Global Radiotherapy Market in 2018

Varian Medical Systems Inc.

Varian Medical Systems Inc. was founded in 1948, and is headquartered at Delaware, (U.S.). Varian Medical Systems Inc. is a provider of radiotherapy, radiosurgery, proton therapy and brachytherapy. Varian Medical Systems Inc. operates its business through two business segments: oncology systems and Varian particle therapy. The company has its presence in Americas, Europe, Middle East & Africa and Asia-Pacific.

Access Full Report https://databridgemarketresearch.com/reports/global-radiotherapy-market/

  • In September 2018, Varian Medical Systems, Inc.(U.S.) signed an agreement with Mediheal Group of Hospitals(Kenya) to expand access to radiotherapy in Kenya. This partnership agreement includes the supply of advanced linear accelerators to five new radiotherapy centers across Kenya which will help in service, training and research collaboration opportunities.
  • In August 2018, Varian Medical Systems, Inc.(U.S.) the acquisition of privately-held humediQ Global GmbH, for radiation therapy. This acquisition expands Varian's motion-management portfolio and is part of the company's long-term growth and value creation strategy.

Elekta AB:

Elekta AB was established in 1972, and is located at Stockholm, Sweden. Elekta AB focuses to provide human care, which specializes in the treatment of cancers and brain disorders. The company operates its business through the solutions and service. The radiotherapy products are available under both business segment solutions and service.  The company has it presence in North and South America, Europe, Middle East and Africa and Asia Pacific.

  • In September 2018, ELEKTA AB (Sweden), announced an agreement with the Siriraj Hospital (Thailand) for advanced radiotherapy technology The acquisition is the part of a major radiotherapy will expand the department will enable Siriraj Hospital clinicians to more effectively treat their cancer patients.
  • In September 2018, ELEKTA AB (Sweden), inaugurated new global radiotherapy innovation center in U.K. This inauguration of the oncology campus will help company to enhance their business which design and manufactures radiation therapy technologies.

ACCURAY, INC.

Accuray, Inc was founded in the year of 1990 and it is headquartered in Sunnyvale CA. Accuray, Inc is engaged to develops, manufactures and sells personalized treatment solutions such as the cyberKnife and tomotherapy systems, which are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company majorly operates its business through two different segments product and services. The radiotherapy products are available in the product and services. It operates its business in Americas, Europe, Middle East, India and Africa, Asia Pacific and Japan.

  • In March 2017, Accuray, Inc (Sunnyvale CA) announced to launch new cancer patient websites. These website www.cyberknife.com and www.tomotherapy.com provides an additional resource for cancer patients to turn to for information about their disease and potential treatment options.

Market Developments:

  • In September 2018, ELEKTA AB (Sweden), announced an agreement with the Siriraj Hospital (Thailand) for advanced radiotherapy technology The acquisition is the part of a major radiotherapy will expand the department will enable Siriraj Hospital clinicians to more effectively treat their cancer patients.
  • In September 2018, ELEKTA AB (Sweden), inaugurated new global radiotherapy innovation center in U.K. This inauguration of the oncology campus will help company to enhance their business which design and manufactures radiation therapy technologies.
  • In March 2017, Accuray announced to launch new cancer patient websites. These website www.cyberknife.com and www.tomotherapy.com provides an additional resource for cancer patients to turn to for information about their disease and potential treatment options.
  • On December 2016, Elekta and Brainlab announced today at the European Society of Stereotactic and Functional Neurosurgery (ESSFN) meeting in Madrid that they have entered into a technical exchange agreement regarding the new software from Brainlab, Elements Stereotaxy and Elekta’s new precise delivery system, Leksell Vantage Stereotactic System.
  • On September 2016, IBA and Royal Phillips announced the launch of a dedicated patient-centric Ambient Experience solution for the proton therapy gantry of IBA’s ProteusPLUS proton therapy solution, making the Philips solution now available for both ProteusONE and ProteusPLUS.